Article in Molecular pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
17 authors.
Md Jashim UddinDepartment of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States.ORCID 0000-0003-0020-4866
Justin Han-Je LoDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States.
Mukesh K GuptaDepartment of Biomedical Engineering, Vanderbilt University School of Engineering, Nashville, Tennessee 37232, United States.ORCID 0000-0002-9571-3454
Thomas A WerfelDepartment of Biomedical Engineering, Vanderbilt University School of Engineering, Nashville, Tennessee 37232, United States.ORCID 0000-0002-6005-1243
Abu AsaduzzamanDepartments of Electrical and Computer Engineering, Wichita State University School of Engineering, Wichita, Kansas 67260, United States.ORCID 0000-0002-5041-1575
Connor G OltmanDepartment of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States.
Eva F GburDepartment of Biomedical Engineering, Vanderbilt University School of Engineering, Nashville, Tennessee 37232, United States.ORCID 0009-0006-4440-464X
Mohammed T MohyuddinDepartment of Biomedical Engineering, Vanderbilt University School of Engineering, Nashville, Tennessee 37232, United States.ORCID 0009-0002-7088-174X
Farhana NazminDepartment of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States.
Md Saidur RahmanDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States.
Ahan JashimDepartment of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States.
Brenda C CrewsDepartment of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States.
Philip J KingsleyDepartment of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States.
Jamie E KlendworthDepartment of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States.ORCID 0009-0001-1518-3589
Lawrence J MarnettDepartments of Biochemistry, Chemistry and Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States.ORCID 0000-0002-7834-6285
Craig L DuvallDepartment of Biomedical Engineering, Vanderbilt University School of Engineering, Nashville, Tennessee 37232, United States.ORCID 0000-0003-3979-0620
Rebecca S CookDepartment of Biomedical Engineering, Vanderbilt University School of Engineering, Nashville, Tennessee 37232, United States.
Funding
FUNCTIONAL ANALYSIS OF CYCLOOXYGENASE 2R01CA089450 · NCI · VANDERBILT UNIVERSITY · PI MARNETT, LAWRENCE J. · 2001 to 2016
$6.3M
In Situ Albumin Binding siRNAs for Triple Negative Breast Cancer Tumor Penetration and Molecularly Targeted TherapyR01CA260958 · NCI · VANDERBILT UNIVERSITY · PI COOK, REBECCA SARA, DUVALL, CRAIG LEWIS · 2021 to 2025
$3.0M
Hybrid Synthetic and Biologic Shear Thinning Hydrogels for Diabetic Wound HealingR01EB028690 · NIBIB · VANDERBILT UNIVERSITY · PI DUVALL, CRAIG LEWIS, GUPTA, MUKESH KUMAR · 2019 to 2023
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Polymeric Nanoparticles Enable Targeted Visualization of Drug Delivery in Breast Cancer. · full record | OpenQuestion